Please assess the completion status of the following clinical trial:

Trial Title: Impact of Laxative Therapy With Lactulose in the Evolution of Organ Dysfunction in Critically Ill Patients.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ICU patients expected to stay for 3 more days, on mechanical ventilation and receiving at least 20% of calculated nutrient intake enterally.~Exclusion Criteria:~* younger than 18 years,~* pregnancy,~* contraindication to enteral nutrition,~* patients with liver disease,~* contraindications to the use of lactulose,~* patients with poor prognosis or without full therapeutic indication investment,~* presence of colostomy or ileostomy,~* intestinal diseases,~* such as disease Crohn's,~* ulcerative colitis,~* short bowel syndrome.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lactulone (Type: EXPERIMENTAL): Patients receiving lactulone
- Control (Type: ACTIVE_COMPARATOR): Observational group. Compare to lactulone group.

Based on this trial design, predict the completion outcome and termination type (if applicable).